Liminatus Pharma exchanges 1M warrants for 350K shares with Alta Partners

Liminatus Pharma, Inc.

• Company issued 350,000 shares of common stock to Alta Partners in exchange for surrender and cancellation of 1,000,000 warrants.
• No commission or other remuneration was paid in connection with the exchange.
• Shares were issued in reliance on the Section 3(a)(9) exemption from registration.
• The transaction reduces potential dilution from outstanding warrants by 650,000 shares on a net basis.